Abvc Biopharma (ABVC) Treasury Shares (2018 - 2026)
Abvc Biopharma's (ABVC) quarterly Treasury Shares came in at $8.9 million in Q1 2026, little changed YoY from $8.9 million in Q1 2025, and little changed on a QoQ basis from $8.9 million in Q4 2025.
Abvc Biopharma (ABVC) Treasury Shares (2018 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 2 years of Treasury Shares data on file, last reported at -$730049.0 in Q3 2024.
- Quarterly Treasury Shares changed 0.0% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $8.9 million, changed 0.0% from the prior year.
- Treasury Shares held at $8.9 million in Q1 2026, from $8.9 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $9.1 million in Q1 2022 to a low of $8.9 million in Q4 2023.
- A 5-year average of $9.0 million and a median of $8.9 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares retreated 2.18% — and 2024, when it climbed 0.09%.
- Tracing ABVC's Treasury Shares over 5 years: stood at $9.1 million in 2022, then fell by 2.18% to $8.9 million in 2023, then grew by 0.09% to $8.9 million in 2024, then changed by 0.0% to $8.9 million in 2025, then changed by 0.0% to $8.9 million in 2026.
- The last three Treasury Shares figures came in at $8.9 million (Q1 2026), $8.9 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | 8.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.91 Mn |
| Jun 30, 2026 | 8.91 Mn |
| Mar 31, 2026 | 8.91 Mn |
| Mar 31, 2026 | 8.91 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | 8.91 Mn |
| Sep 30, 2025 | 8.91 Mn |
| Jun 30, 2025 | 8.91 Mn |
| Jun 30, 2025 | 8.91 Mn |
| Mar 31, 2025 | 8.91 Mn |
| Mar 31, 2025 | 8.91 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | -730,049.00 |
| Sep 30, 2024 | 8.90 Mn |
| Sep 30, 2024 | 8.90 Mn |
| Sep 30, 2024 | -730,049.00 |
| Jun 30, 2024 | -730,049.00 |
| Jun 30, 2024 | -730,049.00 |